Literature DB >> 29727213

Ceftolozane-tazobactam resistance induced in vivo during the treatment of MDR Pseudomonas aeruginosa pneumonia.

Aiden J Plant1, Alexander Dunn1, Robert J Porter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29727213     DOI： 10.1080/14787210.2018.1473079

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN： 1478-7210            Impact factor:   5.091


× No keyword cloud information.
  4 in total

1.  Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates.

Authors:  María Milagro Montero; Sandra Domene-Ochoa; Carla López-Causapé; Inmaculada López-Montesinos; Sonia Luque; Luisa Sorlí; Núria Campillo; Eduardo Padilla; Núria Prim; Lorena Ferrer Alapont; Santiago Grau; Antonio Oliver; Juan P Horcajada
Journal:  Microbiol Spectr       Date:  2022-06-13

2.  Pseudomonas aeruginosa Coharboring BlaKPC-2 and BlaVIM-2 Carbapenemase Genes.

Authors:  Tatiana Pacheco; Rosa Helena Bustos-Cruz; Deisy Abril; Sara Arias; Lina Uribe; Jenny Rincón; Julio-Cesar García; Javier Escobar-Perez
Journal:  Antibiotics (Basel)       Date:  2019-07-20

Review 3.  Ceftolozane/Tazobactam for Resistant Drugs Pseudomonas aeruginosa Respiratory Infections: A Systematic Literature Review of the Real-World Evidence.

Authors:  Luca Gregorio Giaccari; Maria Caterina Pace; Maria Beatrice Passavanti; Francesca Gargano; Caterina Aurilio; Pasquale Sansone
Journal:  Life (Basel)       Date:  2021-05-24

4.  Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project.

Authors:  Zaira R Palacios-Baena; Lucia Valiente de Santis; Natalia Maldonado; Clara M Rosso-Fernández; Irene Borreguero; Carmen Herrero-Rodríguez; Salvador López-Cárdenas; Franciso J Martínez-Marcos; Andrés Martín-Aspas; Patricia Jiménez-Aguilar; Juan J Castón; Francisco Anguita-Santos; Guillermo Ojeda-Burgos; M Pilar Aznarte-Padial; Julia Praena-Segovia; Juan E Corzo-Delgado; M Ángeles Esteban-Moreno; Jesús Rodríguez-Baño; Pilar Retamar
Journal:  BMJ Open       Date:  2020-07-31       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.